Showing results (91-100 of 406) with videos related to

Sort By:
Pageof 41
Acta Physiologica Scandinavica|May 1, 1994
Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomographyG Blomqvist, R J Seitz, I Sjögren, et al.
Psychopharmacology Series|January 1, 1988
PET scanning--a new tool in clinical psychopharmacologyG Sedvall, L Farde, H Hall, et al.
Psychopharmacology|October 1, 1995
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patientsP Karlsson, L Smith, L Farde, et al.
Psychopharmacology|January 1, 1988
An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PETL Farde, F A Wiesel, P Jansson, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1995
Recent developments in PET scan imaging of neuroreceptors in schizophreniaG Sedvall, S Pauli, L Farde, et al.
Neuroscience|July 1, 1995
Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptorsS Brené, H Hall, N Lindefors, et al.
Neurology|April 28, 2004
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsyI Savic, P Lindström, B Gulyás, et al.
Neuroimage|March 21, 2016
Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography dataP Fazio, M Schain, K Varnäs, et al.
Acta Pharmaceutica Nordica|January 1, 1990
Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptorsT Högberg, P Ström, H Hall, et al.
Synapse (New York, N.Y.)|February 1, 1994
PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brainL Farde, C Halldin, L Müller, et al.
Pageof 41